NCT01403142View on ClinicalTrials.gov

Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 18, 2011

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Cardiac Allograft Vasculopathy
Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT01403142 - Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant | Biotech Hunter | Biotech Hunter